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ABSTRACT 
Anions play important roles in biological systems. The design of anion sensors has been 
of great interest. The selective detection of a specific anion is particularly challenging. In the 
first chapter, I describe the synthesis of a TBS-protected fluorescein dye (1.1) and its use for 
the selective detection of fluoride. Solutions of 1.1 either in DCM or in aqueous media at 
physiological pH show the excellent selectivity towards fluoride to afford color formation 
while solutions of other interfering anions remain colorless. 
The monitoring of homocysteine (Hcy) and cysteine (Cys) levels is important since they 
are biomarkers associated with Alzheimer’s and cardiovascular disease, among many others. 
In the second chapter, the selective detection of Hcy and Cys over other amino acids using a 
library of chromogenic reagents and their application in an HPLC post-column system are 
described. 
Saccharides are widely used in industrial processes and biological systems. The 
determination of a specific saccharide is difficult since sugars are colorless and structurally 
similar to each other. Futhermore, the colorimetric detection of oligosaccharides via 
conventional methods is difficult. In the third chapter, I have reported the synthesis of a 
boronic acid-appended rhodamine dye (3.1) and its application towards the detection of 
mono- and oligosaccharides via an HPLC post-column system. The selectivity of 3.1 towards 
fructose allows one to detect fructose in the presence of a 100-fold excess of glucose. The 
detection of sialic acid is also described. 
In the fourth chapter, the elucidation of the mechanism of the origin of color formation 
in resorcinarene macrocyclic compounds is explained in detail. The in situ acid formation 
from DMSO decomposition can cause the ring-opening of resorcinarenes followed by the 
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condensation of resultant products to afford xanthene dyes. This discovery has influenced the 
development of other indicator molecules discussed in the previous chapters. 
In the last chapter, I reported the synthesis of a cysteine-conjugated rhodamine dye and 
its application in the selective detection of α-dicarbonyl compounds and a DNA lesion marker. 
These ongoing research projects will continue. New studies including optimizing sensing 
conditions and the elucidation of selective binding mechanism include future work. 
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CHAPTER 1 
SELECTIVE RECOGNITION OF FLUORIDE WITH A FUNCTIONALIZED 
FLUORESCEIN VIA CHROMOPHORE FORMATION IN AQUEOUS MEDIA 
1.1. Anion Recognition 
The search for artificial anion receptors has been of great recent interest. Anions play 
important roles in biological systems and industrial processes.1.1  Fluoride detection has 
gained attention due to its importance in human health. 
For the past few years, receptors based on hydrogen bonding interactions with anions 
have been intensively evaluated. Receptors are generally designed in combination with a 
responsive functional group and, for sensing, a signaling unit.  Urea, thiourea or pyrrole 
groups have been shown to interact with anions to produce an electrochemical1.2 or an 
optical (UV-Vis/fluorescence) response.1.3 However, the nature of such receptors limits the 
ability for selective recognition towards fluoride in the presence of other anions since 
hydrogen bonding interactions could also occur with other strong electronegative ions. 
Typical interferents include halides and oxygen-containing species such as CH3CO2-, H2PO4- 
and H2SO4-. 
Efforts have been made to improve fluoride selectivity.1.4,1.5 However, these latter 
approaches restrict the choice of solvent, since aqueous or hydrogen bonding media compete 
with fluoride in binding the receptor.1.3a,1..5 Electrochemical signaling can be obtained in 
aqueous media upon the binding of boronic acids to fluoride. The ensuing negative charge on 
boron generates an electrochemical signal via a ferrocenyl subunit.1.6 Visible detection was 
also achieved indirectly in the same system using redox interactions between 
ferrocenylboronic acid and organic dyes.1. 7   In addition, boronic acids conjugated to 
fluorogenic substrates such as benzene or naphthalene were introduced to produce optical 
signals at emission wavelengths below 350 nm over a moderate range of fluoride 
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concentrations (50-70 mM). 1.8 To the best of our knowledge, there has been no report of a 
simple indicator molecule that is selective towards fluoride in the presence of other anionic 
interferents in aqueous solution at physiological pH. Indicator molecules that interact with 
specific anion target molecules can afford significant and characteristic color and/or 
fluorescence signaling.1.9 
Fluorescein is a well-known chromo/fluorogenic compound which shows high 
extinction coefficient and fluorescence quantum yield.1.10 Fluorescein derivatives have been 
intensively utilized in numerous biological applications.1.11 Fluorescein derivatives can exist 
in two tautomeric forms; a colorless/non-fluorescent lactone or highly colored/fluorescent 
quinine (Scheme 1.1). Hence, the controlled manipulation of the tautomeric transition could 
afford a chromogenic and fluorogenic indicator. For example, some functionalized 
fluorescein dyes have been used as photoactivatible fluorophores and as peroxide probes.1.12 
1.2. Selective Detection of Fluoride 
In recent work, I reported the synthesis of a boronic acid functionalized rhodamine dye 
and its application towards the detection of mono- and oligosaccharides.1.13 It is known that 
silicon has a strong affinity towards fluoride. Silyl-protected phenolic hydroxyl groups could 
be effectively cleaved by a reagent containing fluoride.1.14  Thus, conventional fluoride-
induced deprotection would allow us to attain a very simple chromogenic and fluorogenic 
sensor. Silyl-protected fluorescein derivatives are readily synthesized in one step from 
commercially available fluorescein using a standard phenol protection protocol (Scheme 
1.2)1.15 and evaluated as fluoride indicators in aqueous solutions. It has been reported that 
refluxing aryl trimethylsilyl ethers in aqueous MeOH could cause cleavage of the Si-O 
bond.1.14  
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Figure 1.1. Selective detection of fluoride using a colorimetric receptor 1.1 (2.8 × 10-4 M) in 
aqueous media (75 mM triethanolamine buffer at pH 7.5 in 7:3 acetone:water). Each sample 
contains the same concentration of different anionic species as their corresponding 
tetrabutylammonium salt forms (1.5 × 10-3 M each). (a) no analyte, (b) fluoride, (c) chloride, 
(d) bromide, (e) iodide, (f) nitrate, (g) acetate, (h) cyanide, (i) hydrogensulfate. 
 
O OHO
COOH
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(color/fluorescent)
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Scheme 1.1. Tautomeric transition of fluorescein derivatives. 
 
Greater steric hindrance of the silyl protecting group should impart enhanced resistance 
to hydrolysis. Indeed, compound 1.3 exhibits better stability in aqueous solutions. I observed 
that the solutions of 1.3 do not promote any significant change in aqueous solutions for 
overnight. However, we evaluate compound 1.1 as a selective fluoride indicator since 
Compound 1.1 shows balanced sensitivity towards fluoride and water resistance. We observe 
that compound 1.1 promotes the formation of a yellow color from a coloress solution with a 
λmax of 480 nm upon the addition of fluoride. Other anions including chloride, bromide, 
iodide, acetate, cyanide, hydrogensulfate and nitrate (all as tetrabutylammonium salts) do not 
promote any color formation (Figure 1.1).Fluoride has been used for the prevention of tooth 
caries1.16 and in the treatment of osteoporosis.1.17 However, elevated levels of fluoride 
exposure could lead to adverse consequences including dental fluorosis, skeletal fluorosis and 
(a) (d) (e) (f) (g) (h) (i) (c) (b) 
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even acute fluoride poisoning.1.18 In addition, the threat of bio-terrorism utilizing chemical 
warfare reagents has gained enormous attention. For example, organophosphofluoridate 
derivatives including soman and sarin, which are extremely lethal nerve gas agents (Figure 
1.2) and produce fluoride upon reaction with moisture, are well-known. 
 
O
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ORROO OHO
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1.2: R =
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Me
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Scheme 1.2. Synthesis of silyl-protected fluorescein derivatives. 
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Figure 1.2. G-type chemical warfare agents. 
 
It would be very convenient to develop a methodology to detect those chemical warfare 
reagents with an inexpensive and simple detection method.  We are currently exploring this 
with a company that fabricates receptors for sarin, soman and VX (proprietary information). 
The concept of using silyl deprotection of a phenolic moiety in fluorogenic fluoride 
sensors has been reported very recently.1.9d In the first step, silyl cleavage promoted by 
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fluoride occurs to free a phenolic hydroxyl which undergoes a cyclization to afford a 
coumarin derivative in the second step.  
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Figure 1.3. Absorbance vs. concentration plot of 1.1 (2.5 × 10-4 M) upon the addition of 
various anions (0.15 M triethanolamine buffer at pH 7.5 in 7:3 acetone/water) at 490 nm. 1.0 
μmol of each anion was added into the stock solution (7 mL) containing compound 1.1 and 
then stirred for 1 min prior to the UV-Vis spectrum observed. 
 
However, saturation of the fluorescence intensity requires a prolonged period of 
approximately 2 h, even with excess amount of fluoride since the cyclization reaction in the 
fluorescence-producing second step takes place relatively slowly.1.9d Figure 1.4 clearly shows 
that the absorbance signal of 1.1 can saturate upon the addition of fluoride in the non-aqueous 
media in which the previously reported fluoride receptor (vide supra) was studied.1.9d To 
enhance the interaction rate between 1.1 and fluoride, an 8-fold excess of fluoride to each 
silyl group is added. The same experiment is performed in aqueous media (Figure 1.4) at 
physiological pH.  We observe similar yellowish solution forming shortly after fluoride is 
added. Saturation is reached more slowly than in organic media (approximately 18 min), 
presumably due to the stronger hydration of fluoride ion.  
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This is the first example of the application of this technique used directly in buffered 
media. We find that 1.1 possesses high affinity towards fluoride over other anionic 
interferents present even in an excess amount either in DCM or in aqueous media.  
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Figure 1.4. (top) 1.1 (1.0 × 10-5 M) exhibits instant saturation of the absorbance intensity 
upon fluoride addition (8-fold excess to each silyl unit of 1.1) in DCM. (bottom) 1.1 (3.5 × 
10-4 M) with 20 equivalents of fluoride (6.9 × 10-3 M) in 0.24 M triethanolamine buffer at pH 
7.5 in a mixture of 7:3 acetone/water. 
 
Figure 1.5 shows that 1.1 (1.0 × 10-5 M) interacts selectively with fluoride (1.6 ×10-4 M) 
while a 56-fold excess of other anions affords no significant increase in absorbance signals in 
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DCM solution. Not surprisingly, specific recognition of fluoride with a solution containing 
1.1 is also achieved in aqueous media (0.24 M triethanolamine buffer at pH 7.5 7:3 
acetone:water). 
F- C
l-
B
r- I-
N
O
3
-
H
O
S
O
3
-
C
lO
4
-
S
C
N
-
0.0
0.2
0.4
0.6
0.8
1.0
1.2
A
b
so
rb
a
n
ce
 (
A
-A
o
) 
at
 5
1
5
 n
m
F- C
l-
B
r- I-
N
O
3
-
C
H
3
C
O
O
-
C
N
-
H
O
S
O
3
-
H
2
PO
4
-
0.0
0.1
0.2
0.3
0.4
0.5
0.6
Ab
so
rb
an
ce
 (A
-A
o)
 a
t 4
90
 n
m
 
Figure 1.5. Absorbance intensity changes of solutions containing 1.1 with various anions in 
DCM (left) and in a mixture of acetone and water (right). 
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Figure 1.6. log fluorescence emission intensity vs. concentration plot shows that the solution 
of 1.1 (3.4 × 10-4 M) in DCM can monitor fluoride concentration (in tetrabutylammonium 
form) as low as 1.66 × 10-6 M. 
 
Compound 1.1 (1.75 × 10-4 M) combined with fluoride (2.1 × 10-3 M) develops an 
intense yellowish color from a colorless solution. Other anionic interferent-containing 
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solutions (10-fold excess to fluoride) remain colorless under the same conditions. We also 
find that solutions of compound 1.1 (3.4 × 10-4 M) in DCM can detect fluoride concentration 
levels as low as 1.6 × 10-6 M by fluorescence emission spectroscopy (Figure 1.6). 
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Scheme 1.3. Synthesis of polymerizable TBS-protected fluorescein dye (1.5). 
 
We have also synthesized a polymerizable TBS-protected fluorescein derivative (1.5). 4-
Acrylamidofluorescein (1.4) is obtained by the reaction of commercially available 4-
aminofluorescein with acryloyl chloride according to the previously reported procedure.1.19 
Upon protection of hydroxyls with t-butyldimethylsilyl chloride, compound 1.4 furnishes a 
polymerizable fluoride indicator (1.5). We are continuing to study applications of this 
polymerizable compound. 
1.3. Conclusion 
I have synthesized silyl-protected fluorescein derivatives and evaluated their application 
as a selective receptor for fluoride in mixed aqueous neutral buffer solution. Compound 1.1 
can be easily made via a simple one step reaction in a high yield. Compound 1.1 shows 
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excellent selectivity towards fluoride over other interfering anionic compounds in aqueous as 
well as organic media by spectroscopic detection. 
1.4. Experimental Section 
Synthesis of compound 1.1; fluorescein (1.5g, 4.5 mmol), imidazole (1.23g, 18 mmol), 
and t-butyldimethylsilyl chloride (2.72g, 18 mmol) are combined in 5 mL of dry DMF. The 
solution is stirred at 65 °C for 24 h under N2. The viscous liquid is dissolved in 100 mL 
EtOAc and the organic layer washed with H2O (50 mL × 6), dried with MgSO4, and filtered. 
The solvent is evaporated in vacuo to afford a crude product. For further purification, column 
chromatography is performed with EtOAc and hexanes (2:8 to 3:7). The fraction isolated is 
dried in vacuo to afford 2.18g of 1.1 (86 %). Analytical data for 1.1: 1H NMR (300 MHz, 
CDCl3) δ (ppm): 0.23 (s, 12H), 0.99 (s, 18H), 6.52 (dd, J = 8.6 and 2.3 Hz, 2H), 6.64 (d, J = 
8.6 Hz, 2H), 6.73 (d, J = 2.3 Hz, 2H), 7.19 (d, J = 7.3 Hz, 1H), 7.59-7.70 (m, 2H), 8.02 (d, J 
= 6.87 Hz, 1H); 13C NMR (300 MHz, CDCl3) δ (ppm): -4.21, 18.41, 25.81, 83.49, 107.83, 
112.26, 116.80, 124.21, 125.15, 127.06, 129.19, 129.81, 135.13, 152.50, 153.38, 157.78, 
169.67; MALDI-MS m/z (dithranol matrix) calculated for C32H40O5Si2 560.2 M+, found 
561.5 [M+H]+. 
Synthesis of compound 1.2; To the solution of fluorescein (2.1 g, 6.3 mmol) and 
imidazole (1.72 g, 25.3 mmol) in 150 mL of dry DMF is added triisopropyl silyl chloride (4.0 
mL, 18.7 mmol). After the mixture is stirred for 16 h at room temperature, the solvent is 
evaporated in vacuo. The resultant mixture is combined with 200 mL of distilled water, 
extracted with EtOAc (200 mL + 150 mL × 3). The organic layers are combined, washed with 
saturated NaCl solution (200 mL) and dried with MgSO4 to afford crude 1.2. For further 
purification, column chromatography is performed with a mixture of hexanes, toluene and 
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EtOAc (8:1:1) to afford 562.5 mg of 1.2 (13.8 %). Analytical data for 1.2: 1H NMR (250 
MHz, CDCl3) δ (ppm): 1.10 (d, J = 6.68 Hz, 36H), 1.26 (m, 6H), 6.55 (dd, J = 8.6 and 2.3 Hz, 
2H), 6.63 (d, J = 8.6 Hz, 2H), 6.76 (d, J = 2.3 Hz, 2H), 7.17 (d, J = 6.7 Hz, 1H), 7.63 (m, 2H), 
8.01 (d, J = 6.48 Hz, 1H). 
Synthesis of compound 1.3; To the solution of fluorescein (3.0 g, 9.0 mmol) in 10 mL of 
dry DMF are added imidazole (2.464 g, 36.1 mmol) and t-butyldiphenylsilyl chloride (7.0 
mL, 26.9 mmol). The mixture is stirred for 16 h at 65 °C under N2 and poured in 100 mL of 
H2O. The yellowish suspension in the aqueous solution is recovered by filtration and washed 
with H2O again. The solid materials are dissolved in diethyl ether, dried with Na2SO4 and 
filtered. The solvent is removed by evaporation in vacuo to afford crude 1.3. For further 
purification, column chromatography is performed with EtOAc and hexanes (2:8) to attain 
6.936 g of 1.3 (95 %). Analytical data for 1.3: 1H NMR (250 MHz, CDCl3) δ (ppm): 1.08 (s, 
18H), 6.37 (dd, J = 8.7 and 2.3 Hz, 2H), 6.43 (d, J = 8.7 Hz, 2H), 6.62 (d, J = 2.3 Hz, 2H), 
7.06 (d, J = 6.93 Hz, 1H), 7.38 (m, 12H), 7.54 (m, 2H), 7.69 (d, J = 6.9 Hz, 8H), 7.91 (d, J = 
7.4 Hz, 1H). 
Synthesis of compound 1.5; 4-Acrylamidofluorescein (1.4) is synthesized according to 
the previously reported procedure.1. 19  4-acrylamidofluorescein (800 mg, 2.0 mmol), 
imidazole (1.2 g, 8.0 mmol) and t-butyldimethylsilyl chloride (543 mg, 3.6 mmol) are 
dissolved in 5 mL of dry DMF. The mixture is stirred for 17 h under N2. To the solution is 
added 100 mL of EtOAc. The organic layer is washed with H2O (75 mL × 5), dried with 
MgSO4, filtered and evaporated in vacuo. The resultant mixture is purified by column 
chromatography (EtOAc:Hexanes 6:4) to attain 392 mg of 1.5 (31.2 %). Analytical data for 
1.5: 1H NMR (300 MHz, DMSO-d6) δ (ppm): 0.21 (s, 12H), 0.93 (s, 18H), 5.84 (d, J = 9.3 
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Hz, 1H), 6.33 (d, J = 17.1 Hz, 1H), 6.47 (dd, J = 17.1 and 9.3 Hz, 1H), 6.72 (m, 6H), 7.27 (d, 
J = 7.8 Hz, 1H), 7.89 (d, J = 7.8 Hz, 1H), 8.44 (s, 1H), 10.63 (s, 1H). MALDI-MS with 
dithranol m/z calculated for C35H43NO6Si2 629.26 for M+, found 630.84 [M+H]+. 
All UV-Visible spectra are recorded on a Spectramax Plus 384 spectrophotometer 
(Molecular Devices). 
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CHAPTER 2 
SELECTIVE DETECTION OF AMINOTHIOLS VIA A HPLC POST-COLUMN 
SYSTEM*,2.1 
2.1. Aminothiols in Human Health 
Elevated levels of homocysteine (Hcy) in human plasma are associated with severe 
diseases. For instance, hyperhomocysteinemia is involved in cardiovascular disease,2. 2 
Alzheimer’s disease,2. 3    complications during pregnancy2. 4    and osteoporosis.2. 5 
Homocystinuria has also been linked to mental retardation and neurodegeneration. Cysteine 
(Cys) deficiency is associated with numerous disorders including liver damage, slowed 
growth, hair depigmentation, skin lesions and fat and muscle loss.2.6 In addition, elevated 
levels of both Cys and Hcy are related to neurotoxicity. Glutathione (GSH) which is a 
tripeptide amino acid covalently linking cysteine, glycine and glutamic acid residues is 
known as a beneficial antioxidant. 
2.2. The Detection of Hcy and Cys by Thiazolidine and Thiazinane Formation 
It has been long-known that Cys can react with carbonyls. Aldehydes readily react with 
N-terminal Cys to form thiazolidine products. Thiazolidine formation has been employed to 
selectively label proteins with N-terminal Cys2.7 residues and in stereospecific litigations of 
peptides.2.8  Oxazolidine formation, in contrast, from the reaction of an amino alcohol and an 
aldehyde, is not highly favored in aqueous media. It has been found that thiazolidines are 104 
times more stable than oxazolidines.2.8 
Lippard et al. initially obtained compound 2.6 via a multi-step synthesis.2.9 Recently, a 
co-worker in the Strongin group synthesized 2.6 in one step via a Reimer-Tieman reaction 
using commercially available fluorescein.2.10 
 
* Reproduced in part with permission from Journal of the American Chemical Society, 2005, 
volumn 127, pages 15949-15958; Copyright 2005 American Chemical Society. 
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Figure 2.1. Some bioactive aminothiols. 
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Scheme 2.1 The reaction of 2.6 with Cys and Hcy to afford bis-thiazolidine (n=1) and bis-
thiazinane (n=2). 
 
Our group observed that a solution containing 2.6 (1.0 × 10-3 M) changes color from 
bright yellow to brownish-orange upon the addition of Cys or Hcy (1.0 × 10-6 M) in 0.01 M 
pH 9.5 carbonate buffer. In addition, similar observations were also attained when the 
solution of 2.6 (1.0 × 10-3 M) was co-spotted with or without various analytes (1.0 × 10-3 M) 
on C18-bonded silica plate. 
Hcy possesses an oxidizing thiol moiety which easily forms a disulfide bond in the 
presence of O2. Only less than 1% of Hcy exists in a reduced form (free Hcy) in a biological 
system while the rest of Hcy is covalently bound to other sulfhydryl groups (e.g. Hcy, Cys 
and GSH) as disulfide forms. Therefore, the concentration of total Hcy (tHcy) has often been 
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used to indicate the concentration of Hcy in biological samples. The level of tHcy is found to 
be less than 1.2-1.5 × 10-5 M in healthy human plasma, which is typically 20-30 times less 
than that of Cys. Absorbance changes in solutions of 2.6 were clearly observed in the range of 
10-5-10-6 M of Cys with a red-shift in wavelength of 25 nm (Figure 2.3). 
 
 
 
Figure 2.2. (Left) solutions containing 2.6 with and without various analytes (a) control, (b) 
Cys, (c) Hcy, (d) bovine serum albumin, (e) glycine and (f) n-propylamine (Right) 
observations on C18-bonded silica plates exposed to visible and UV light. 
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Figure 2.3. Absorbance vs concentration plot for solutions containing 2.6 (2.5 × 10-6 M, pH 
9.5 carbonate buffer) with added Hcy (○) or Cys (▲). The addition of Hcy and Cys (5.0 × 10-
6 M) to 2.6 showed an absorbance decrease at 480 nm. An increasing absorbance was 
monitored at 505 nm with a Hcy or Cys concentration range from 1.0 × 10-5 to 4.0 × 10-5 M 
under the same conditions. 
 
1H NMR and mass spectroscopic studies confirmed the formation of thiazolidines and 
thiazinanes.2.11 Solutions of 2.6 in the presence of an equimolar amount of Hcy or Cys 
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showed similar absorbance changes while only a minimal change was monitored in the 
solutions of 2.6 with an excess of other analytes (8.0 × 10-4 M). Less than 15% of an 
absorbance change was observed at 480 nm without any wavelength shift. 
 
RS   +   RS                   RSSR (1)
RS                   CR (2) 
 
Figure 2.4. Equilibrium reactions to form reducing radicals. 
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Scheme 2.2. Carbon-centered radical formation of aminothiols by intramolecular hydrogen 
abstraction. 
 
Amines (glucosamine HCl and n-propylamine), thiols (methionine, mercaptoethanol and 
GSH) and amino acids (glutamine, serine, glycine and glutamic acid) were included in the 
screening. This corroborates the high selectivity of 2.6 towards Hcy and Cys over other 
possible interferents. 
In addition, a spectral change in deproteinized human plasma solutions containing 2.6 
upon the addition of healthy-to-abnormal level of Cys or Hcy was also monitored via UV-Vis 
absorbance or fluorescence quenching.2.11 
2.3. The Selective Detection of Hcy by MV2+ and Fluorone Black 
Thiyl radicals can be attained via the oxidation process of thiols in nature.2.12 The 
oxidizing thiyl radicals can either form the reducing α-amino carbon-centered radical via an 
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intramolecular hydrogen abstraction or react with a thiolate anion to afford a reducing 
disulfide radical anion (Figure 2.4). It has been reported that the α-amino carbon-centered 
radical of Cys and GSH could be formed by the intramolecular hydrogen abstraction of a 
thiyl radical. 
 
 
 
Figure 2.5. The solution of 2.7 shows the selective response to Hcy; (a) control, (b) Cys, (c) 
Hcy and (d) GSH. 
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Figure 2.6. The electron transfer of the reducing α-amino carbon-centered radical of Hcy to 
2.7 and 2.8. 
 
Recently, Zhao et al. reported that the formation of the α-amino carbon-centered radical 
of Hcy should be more favorable due to a favored five-membered ring transition state during 
the intramolecular hydrogen abstraction process (Scheme 2.2).2.13a 
Methyl viologen dication (1,1’-Dimethyl-4,4’-bipyridinium dication; MV2+ 2.7) is a 
moderate electron acceptor. When colorless 2.7 captures an electron, MV·+ exhibits 
characteristic blue color. 2.7 was used in the study of the equilibrium kinetics of the reducing  
(a) (b) (c) (d) 
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α-amino carbon-centered radicals and the reducing disulfide radical anions derived from the 
thiyl radicals of GSH, Cys and Hcy at pH 10.5.2.13 
The concentration of thiolate anion is only minimal to that of sulfhydryl group (pKa ≈ 
9.5) at physiological conditions. The predominant hydrogen abstraction process should 
warrant the selectivity for Hcy over other aminothiols. In addition, the reducing α-amino 
carbon-centered radicals should be readily formed under basic conditions since they can be 
captodatively stabilized by the rearrangement of the deprotonated amine moiety. Thus, no 
selectivity among GSH, Cys and Hcy would be observed.  
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Figure 2.7. UV-Vis spectra of the solutions of 2.8 with or without aminothiols. 
 
We therefore envisioned that the selective detection of Hcy would be possible via the 
redox reaction of 2.7 at physiological conditions. We observed that heating the colorless 
solution containing 2.7 (4.0 mM in 0.1 M Tris buffer at pH 7.5) to reflux (5 min) turns to a 
bluish color upon addition of Hcy (17.0 mM). In contrast, no color formation with either 
GSH or Cys was observed at the same conditions. The new appearance of absorbances at 398 
nm and 605 nm was monitored by UV-Vis spectrophotometer.2.14 We have also investigated 
 19
the commercially available fluorone black as an electron acceptor. The solution of 2.8 (1.0 × 
10-5 M) in a mixture of methanol and water (7:3) at pH 7.3 exhibit an absorbance increase at 
510 nm upon the addition of 10-fold excess Hcy (1.0 × 10-4 M) at room temperature. 
However, equimolar amount of other aminothiols including GSH, Cys and penicillamine 
(Figure 2.1) promote relatively smaller increase of an absorbance (Figure 2.7). 
 
 
 
Figure 2.8. UV-Vis spectra of solutions containing 2.8 (1.0 × 10-5 M, pH 7.3 15 mM 
phosphate buffer, 3:7 H2O:MeOH) with added PPh3 (5.0 × 10-4 M) and aminothiols (1.0 × 10-
5 M). 
 
No significant change is observed in the presence of other amino acids (glycine, serine, 
methionine, alanine, glutamine, lysine, threonine and arginine) and homocystine (a disulfide 
form of Hcy).2.14 We found that the added PPh3 solutions containing 2.8 show the similar 
pattern of an absorbance increase at 510 nm as they do with the addition of Hcy. Interestingly, 
a phosphine is often used as a reductant to reduce biological disulfide bonds. 31P NMR study 
showed that the formation of triphenylphosphine oxide (TPPO) is promoted when the 
solution of 2.8 is combined with PPh3. The formation of TPPO was not detected in the PPh3 
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solution without added 2.8 for 19 h. In fact, it is well-known that TPPO can be formed via the 
radical cation of PPh3. No spectral change is observed in the solutions containing fluorescein 
with added Hcy or Cys. 
These observations suggest that the spectral changes of 2.8 upon the addition of 
aminothiols are caused by the formation of a semiquinone radical in 2.8.  
The electron transfer of the reducing α-amino carbon-centered radicals to 2.8 raise the 
pKa of 2.8 to afford an absorbance increase at 510 nm. Identical spectral changes can be 
observed in the solutions of 2.8 under basic conditions (Figure 2.6). PPh3 could compete with 
thiols reducing 2.8. Since Hcy can act as the best reducing agent among other aminothiols 
listed above (Figure 2.1), the controlled PPh3 addition would suppress the interactions of 2.8 
with other aminothiols except for Hcy. Indeed, we found that at least 45-fold excess PPh3 to 
the solution of 2.8 is required to inhibit any absorbance changes from aminothiols except for 
Hcy which exceptionally affords a significant absorbance increase (Figure 2.8). In addition, 
we found that solutions of 2.8 (1.0 × 10-5 M) with added PPh3 (1.5 × 10-3 M) can allow us to 
selectively detect a physiological level of Hcy (1.0 × 10-5 M) in the presence of 30-fold 
excess of Cys as compared to the spectrum of Hcy alone under identical conditions.2.14 We 
successfully quantified Hcy in deproteinized human plasma samples via the standard addition 
method. The linear working range for Hcy was from 0 to 15 µM.2.14 
2.4. Introduction of HPLC Post-Column Detection of Aminothiols 
The determination of biological thiols has been performed by high-performance liquid 
chromatography (HPLC) in conjunction with analyte derivatization. Most of the 
derivatization methods proceed by formation of disulfide bonds or electrophilic alkylations of 
activated halides with thiol-containing compounds. Most derivatization reagents are not 
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selective towards a specific thiol and have several limitations and drawbacks.2.15  
For example, N-substituted maleimide (2.10) requires the complete conversion to 
hydrolysis products. Otherwise the peak from the reaction intermediates could be monitored. 
The self-hydrolysis of 2.10 could significantly compete with the thiol modification above pH 
8.2.17  
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Figure 2.9. Common thiol-derivatization reagents. 
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Figure 2.10. Chromatograms of mixtures of Cys and Hcy. Inset; (a) histidine, methionine and 
glutamine and (b) lysine, glycine and serine. Conditions: Mobile phase: 100 % of HPLC 
grade water; mobile phase flow rate: 1.5 ml/min; reagent: 2.8 (1.25 × 10-5 M) in 50/50 (v/v) 
mixture of MeOH and aqueous carbonate buffer (0.25 M, pH 9.5); reagent delivery pressure: 
40 psi; reactor temperature: 80 °C.; detector wavelength: 505 nm. 
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Monobromobimane (2.11) is unstable at room temperature. In addition, the choice of 
buffer components is limited due to their possible nucleophilic reactions with 2.11.2.16 The 
sample preparation with 7-fluoro-2,1,3-benzoxadiazole (2.12) or dansylaziridine (2.13) 
requires a prolonged reaction time (1 h at 60 °C). o-Phthalaldehyde (2.14) produces photo-
unstable thiol-adducts and undergoes cross-reactivity with primary amines.2.15,2.17 Recently, I 
reported that a boronic acid functionalized rhodamine dye can serve in the detection of mono- 
and oligosaccharides via HPLC post-column system.2.18 I herein describe the application of 
our library of aminothiol selective reagents in an HPLC post-column detection system. In 
addition, our derivatization reagents absorb at visible wavelengths (> 500 nm) which are 
preferred because many biological interferents absorb below 400 nm.2.15  
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Figure 2.11. Chromatograms of mixtures of Cys and Hcy using 2.6 as post-column reagent. 
(a) separation using HPLC grade water as mobile phase. (b) using TFA 6.5 mM to improve 
separation. 
 
2.5. Experimental Results of HPLC Post-Column Detection of Aminothiols 
In Figure 2.10 two sharp peaks are observed upon the injection of Cys and Hcy (28.8 
nmol each) using the HPLC post-column system with 2.8 as a chromogenic reagent. 
Interestingly, equimolar amounts of six different amino acids including histidine, methionine, 
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glutamine, lysine, glycine, and serine shown on Figure 2.10 (inset) do not produce any 
absorbance change at the same wavelength. As shown in these chromatograms, Cys and Hcy 
can be selectively detected without any significant interference from other amino acids. 
Compound 2.6 is also used as reagent for HPLC post-column detection. In Figure 2.11a, 
two sharp peaks are observed when 43 nmol each of Cys and Hcy are injected. 
 
0 1 2 3 4 5 6 7 8
-0.001
0.000
0.001
0.002
0.003
Ab
so
rb
an
ce
 a
t 5
10
 n
m
Retention Time (min)
 (a)
0 1 2 3 4 5 6 7 8
-0.001
0.000
0.001
0.002
0.003
5.318
Ab
so
rb
an
ce
 a
t 5
10
 n
m
Retention Time (min)
Homocysteine
(b) 
Figure 2.12. (a) Chromatogram of a sample of human plasma using 2.6 as post-column 
reagent. Lyophylized plasma was reconstituted with water (1 mL) and mixed with 100 µL of 
TFA and then diluted five times with water and filtered before injection. The mobile phase 
flow rate was 1.0 mL/min. (b) chromatogram of a sample of human plasma spiked with Hcy 
using 2.6 as post-column reagent. The reconstituted plasma (1 mL) was mixed with 100 µL of 
TFA was diluted ten times with water, spiked with 9.5 nmol of Hcy and filtered before 
injection. 
 
To obtain better separation, we switch the mobile phase from 100 % water to aqueous 
TFA (6.5 mM) (Figure 2.11b). Other conditions for both systems are as follows: mobile phase 
flow rate: 1.5 mL/min; reagent: 2.6 (6.4 × 10-6 M in carbonate buffer 0.125 M, pH 9.5); 
reagent delivery pressure: 40 psi (a: 100% HPLC water), 60 psi (b: aqueous TFA solution); 
reactor temperature: 80 °C; detector wavelength: 510 nm.  
I also studied the same post-column reagent for the detection of Hcy in human plasma. 
2.6 (3.2 × 10-6 M) is prepared in 0.125 M of pH 9.5 aqueous carbonate buffer and delivered 
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by 40 psi of pressure. The mobile phase is 6.5 mM aqueous TFA with a flow rate of 1.0 
mL/min. The reactor temperature is set to 80 °C. Absorbance is monitored at 510 nm. 1 mL 
of human plasma (reconstituted) is mixed with 100 µL of TFA and passed through an Alltech 
Polypure ll 0.2 µm filter without any further purification. The plasma sample is freshly 
prepared before the HPLC injection. 
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Figure 2.13. Chromatogram of a mixture of Cys and Hcy (85 nmol each) using 2.7 as post-
column reagent. 
 
We observe that the peak corresponding to spiked free Hcy in plasma clearly appears at 
5.3 min. The injection of twice the amount of plasma sample alone does not afford any 
significant peaks at 5.3 min. (Figure 2.12)  
In addition, the peak for Hcy is well resolved from that of Cys (3.6 min) under the same 
conditions.2.19 
Using 2.7 as a post-column detection reagent results in selective detection of both Cys 
and Hcy but is qualitatively less sensitive than the other reagents tested. Conditions: mobile 
phase: TFA (0.01 M); mobile phase flow rate: 1.5 ml/min; reagent: 2.7 (0.01 M) in 0.25 M 
carbonate buffer, pH 9.5; reactor temperature: 80°C; detector wavelength: 610 nm. 
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2.6. Conclusion 
I have demonstrated the selectivity of compounds 2.6, 2.7 and 2.8 towards aminothiols 
and their potential utility for the selective detection of aminothiols in an HPLC post-column 
system. 
2.7. Experimental Section 
The general reaction conditions and equipment used in our post-column detection 
methods are as follows: An RDR-1 reagent delivery/reaction module (Timberline) equipped 
with a 110B solvent delivery module (Beckman) and a SpectroMonitor 3200 UV-Vis detector 
(LDC/Milton Roy), using a LiChrospher 100 RP-18 end-capped column (4.6 mm × 250 mm, 
Alltech Associates Inc.), particle diameter of 5 μm. The RDR-1 unit contains a reagent 
reservoir, a mixing tee, and a teflon reaction coil (0.02" ID × 3 m, with a nominal volume of 
0.6 mL) cast in a tin alloy heating block connected to a temperature controller. Other 
conditions specific to the different experiments are described above. 
All UV-Visible spectra are recorded on a Spectramax Plus 384 spectrophotometer 
(Molecular Devices). 
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CHAPTER 3 
SELECTIVE SUGAR DETECTION USING A HPLC POST-COLUMN SYSTEM WITH A 
RHODAMINE-BASED BORONIC ACID*,3.1 
3.1. Introduction 
Novel boronic acid-appended rhodamine dye (3.1) promotes the detection of mono- and 
oligosaccharides via an HPLC post-column system with a standard UV-Vis detector. These 
saccharides include fructose, glucose, maltotriose, maltohexaose and sialic acid. The use of 
selective, reversible binding agents in automated HPLC assays should allow for improved 
monitoring of specific analytes as well as material recovery. 
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Figure 3.1. Rhodamine-based boronic acid (3.1) 
 
3.2. The Drawbacks of Common Saccharide Detection Methods 
The monitoring of specific saccharides has been considered a great challenge in a molecular 
recognition due to their conformational diversity and similar functionality. The direct 
measurement of saccharides with UV-Vis detectors below 210 nm limits solvent choice and 
requires ultra-pure solvents. Measuring refractivity is very common for the detection of 
carbohydrates. However, it is not highly sensitive for the low concentration of samples (≤10 
nmol). 
 
*Reproduced in part with permission from Organic Letters, 2003, volume 5, pages 5007-5010; 
Copyright 2003 American Chemical Society. 
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In addition, it is much liable to the change of solvent composition and column temperature. 
Electrochemical detection by pulsed amperometric detection (PAD) often requires elevated pH 
conditions (>pH 13). Mass spectrometry detection, coupled with chromatographic separations, 
requires very expensive and customized equipments.3.2 Radioactive labeling has also been used 
for radioactivity monitoring. It requires the handling of dangerous radioactive substances. Most 
recently, Evaporative light scattering detection (ELSD) has gained great attention for 
chromatographic sugar detection. However, low molecular weight compounds could have a 
drawback of the potential evaporation along with the mobile phase. 
 
 
 
Figure 3.2. Flow diagram of HPLC post-column system. 
 
3.3. The Detection of Saccharides via HPLC Pre/Post-column System 
The direct measurement of carbohydrates with common optical instruments (UV-Vis or 
fluorescence spectrophotometer) is difficult since carbohydrates do not contain fluorogenic 
and/or chromogenic functionalities. Recently, chemical derivatization, also called reaction 
detection (transforming analytes to spectrophotometrically detectable forms), has been of 
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concern.3.3 Carbohydrates may be derivatized with chromopohores or fluorophores prior to 
separation; however, this procedure can hamper separation via the appendage of moieties with 
intrinsically similar properties. Post-column derivatization techniques have thus attracted great 
attention in carbohydrate analysis.3.2,3.3,3.4 
The most important advantages of a HPLC post-column detection system are that the 
analytes, for instance, monosaccharides are separated through the appropriate column without 
destroying their original forms. In addition, the previously published separation procedures for 
analytes could be adopted. 
Classical methods for carbohydrate derivatization include the conversion of carbohydrates 
to furfural derivatives. Upon treatment of carbohydrates with strong mineral acids, carbohydrates 
are converted into furfural which reacts with a proper chromogenic reagent (for instance, 
resorcinol,3. 5  orcinol,3. 6  phenol,3. 7  etc.). In addition, periodate oxidation of carbohydrates 
produces aldehydes which are combined with other reagents such as amines and β-diketones or 
β–oxo esters compounds to attain pyridine derivatives by the Hantzsch pyridine synthesis.3.8 The 
resultant pyridine derivatives can be monitored in the UV-Vis region. However, the formation of 
pyridine derivatives might be hindered by the excess periodates which has to be reduced by the 
addition of sodium arsenite.3.9 Fe(III) or Cu(II) can be reduced by reducing carbohydrates to 
form Fe(II) or Cu(I) respectively. The use of the reagents which only chelates with the lower 
oxidation state of metal can be applied for the reducing carbohydrate derivatizations. For 
instance, the mixture of Cu2+ and 2,2’-bicinchoninate has been used for this purpose.3.10 The 
direct reaction of derivatization reagents including alkylamines,3.11 2-cyanoacetamide3.12 and 
benzamidines2.13 with reducing carbohydrates has also been studied.  
However, many older automated detection systems based on a specific, post-column 
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reaction of sugars require specially designed acid-resistant reagent delivery and detection 
systems, cause excessive peak broadening and are incompatible with certain solvents used for 
separations.3.3,3.4 
 
O
O
O
NH2H2N
B
CHO
OH
OH
1.
2. NaBH4, MeOH
81%
Rhodamine 110
3.1
 
 
Scheme 3.1. Synthesis of 3.1 
 
More recently, milder reactions with fluorogens have been reported.3.14 The reagents 
currently used in post-column derivatization are typically selective for a family of compounds 
(for instance, aldoses, ketoses, uronic acids, aminosugars, etc.). The reactions are irreversible. 
The use of more selective synthetic chromogenic and/or fluorogenic receptors as post-column 
detection agents could significantly improve the analysis of a component of interest. 
Moreover, if binding is via non- or reversible covalent interactions, recovery of expensive 
or scarce biomolecules should be possible. Herein we report the use of new rhodamine-derived 
boronic acid 3.1 as a post-column derivatization agent in an automated HPLC method towards 
the detection of a variety of sugars and related biomolecules. 
3.4. Results 
Recently, we reported that xanthene dye-functionalized boronic acids can be formed in situ 
from resorcinarenes.3.15 These compounds were used towards the detection of several mono- and 
oligosaccharides.3.15,3.16 It is well-known that boronic acids can react with the diol moieties of 
sugars to form cyclic esters using strong covalent bonds. 
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Scheme 3.2. Equilibia between diols and boronic acids.3.17 
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Scheme 3.3. Intramolecular boron-nitrogen interaction.3.18 
 
The formation of cyclic ester is pH-dependant in aqueous media. Since phenylboronic acid 
has a pKa of ≈8.8,3.19 the significant formation of cyclic esters requires alkaline conditions to 
attain tetrahedral boronate esters. To monitor sugars at physiological pH, a lower pKa value of 
boronic acid is required. 
Lowering the pKa of boronic acids can be attained in the modification of boronic acids 
involving electron-withdrawing effects. For examples, 4-carboxy-3-nitrophenylboronic acid3.20 
and N-methylpyridiniumboronic aicd3.21 exhibit pKas of 7.0 and 4.4 respectively. Wulff has 
introduced the concept of an interamolecular B-N interaction which substantially lowers the 
pseudo pKa of boronic acids.3.22 This concept has recently been adopted by S. Shinkai and co-
workers in the development of saccharide sensor, 9,10-Bis[[N-methyl-N-(o-
boronobenzyl)amino]methyl] anthracene, which shows the pKa of ≈5.0.3.23 
In the current work, we functionalize a related rhodamine scaffold due to its high molar 
absortivity in the visible region3. 24  as well as the potential for favorable boron-nitrogen 
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interactions to promote sugar-boronate formation.3.25 Compound 3.1 is readily synthesized via a 
reductive amination reaction between commercially available rhodamine 110, 2-
formylphenylboronic acid and NaBH4 (Scheme 3.1). 
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Figure 3.3. UV-Vis spectra of solutions of 3.1 (1.64 × 10-5 M, 0.16 M pH 9.5 carbonate buffer in 
1:2 MeOH:H2O) upon titration with D-fructose. The final concentration of fructose was 8.33 × 
10-4 M. 
 
It exhibits selectivity for fructose over glucose in solution, in keeping with the behavior of 
most boronic acid derivatives.3.25 We observe a blue shift of the λmax from 550 nm to 530 nm 
upon addition of D-fructose or D-glucose (Figure 3.3). This observation of a blue shift in UV-Vis 
spectrum could be explained by the formation of partial positive charge on the nitrogen moiety of 
compound 3.1 through the B-N interaction. The apparent equilibrium constant for the interaction 
of 3.1 and D-fructose is 3,806 M-1; for D-glucose the value is 375 M-1. 
Fructose is a common energy source and sweetener metabolized at a high rate in animals 
and humans. High D-fructose intake is implicated in the pathogenesis of hypertriglyceridaemia, 
atherosclerosis 3.26 and insulin resistance. 3.27 Non-enzymatic glycosidation products form more 
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rapidly from fructose than from glucose.3.28 Further elucidation of the biochemical role of D-
fructose requires better methods of analysis.  For instance, the determination of the relatively 
low fructose levels in human plasma is hampered, due, in large part, to excess (ca. 100-fold) 
glucose.3.29 
 
glucose
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Figure 3.4. (Top) chromatogram of a 1:1 mixture of D-fructose and D-glucose (20.0 μg, λ=560 
nm). (Bottom) chromatogram of a mixture of D-fructose (4.5 μg) in the presence of a 100-fold 
excess of D-glucose. 
 
Levels of fructose reported vary among laboratories and on the technique employed, 
including enzymatic detection.3.30 We can monitor mixtures of D-glucose and D-fructose via 
automated post-column HPLC detection with 3.1.  
We clearly observe a peak for D-fructose even in the presence of a 100-fold excess of D-
glucose (Figure 3.4). 
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Figure 3.5. Continuous variation plot (Job’s plot) indicates 1:1 stoichiometry in the interaction 
of 3.1 with fructose. 
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Figure 3.6. UV-Vis spectra of solutions of 3.1 (4.2 × 10-5 M, 0.25 M pH 10.4 carbonate buffer in 
1:1 MeOH:H2O) with oligosaccharides. The final concentration of oligosaccharides was 8.0 × 
10-3 M. 
 
The stoichiometry of the interaction of compound 3.1 with fructose is measured by the 
continuous variation method (Job’s plot). The result clearly shows a 1:1 complex of compound 
3.1 and fructose in 0.125 M pH 9.5 carbonate buffer in 1:1 MeOH:H2O solution (Figure 3.5). 
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NMR studies of 13C-labelled D-fructose could be used to identify what isomers are involved in 
the complex formation with 3.1.3.31 
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Figure 3.7. Structure of maltotriose (n=1) and maltohexaose (n=4). 
 
 
Figure 3.8. Chromatogram of a 1:1 mixture of (A) maltohexaose and (B) maltotriose (80 μg, 
λ=560 nm). 
 
The new post-column detection method is also applicable to the monitoring of 
oligosaccharides. Current oligosaccharide colorimetric HPLC detection methods typically 
require prior complete hydrolysis to monosaccharides or pre-column covalent attachment to a 
chromophore.3.32,3.33 
The classical color tests used for HPLC post-column detection of monosaccharides cannot 
be used to directly detect oligosaccharides containing more than three residues.3.32 The 
colorimetric response is only related to the molar concentration of oligosaccharide, not the 
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concentration by weight.3.32 Recently, We can apply these findings to the colorimetric HPLC 
detection of oligosaccharides. Under similar conditions (reactor temperature set to 94 ºC) to 
those used for the monosaccharides above, mixtures of maltotriose and maltohexaose (80 g) can 
be monitored (Figure 3.8).  
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Figure 3.9. Structures of N-acetylneuraminic acid and GM1 ganglioside.3.34 
 
This observation of higher oligomer detection can be confirmed by previous studies.3.15,3.35 
The interaction of oligosaccharides with arylboronic acids shows an increase of binding 
constants with higher oligomers.3.35 The formation of boronate esters occurs with the diol of the 
reducing sugar termini. The binding of oligosaccharides is enhanced by the secondary CH-π 
interactions with arylboronic acids. The higher oligomers possess greater flexibility in their 
structure and can easily achieve the proper conformation to interact with the receptor molecule. 
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In addition, we reported that boronic acid-functionalized xanthenes allowed us to generate strong 
colorimetric responses for larger oligosaccharides.3.15 
 
0 5 10 15 20
time (min)  
 
Figure 3.10. Chromatogram of GM1 (220 μg, λ=520 nm). 
 
Sialic acids are found in glycoproteins, glycopeptides and glycolipids. They play important 
roles in cellular communication in human body. Unbalanced sialic acid levels can lead to 
alterations in cell adhesion, which is implicated in certain cancers and graft rejection. An 
increase in the levels of both soluble and cellular sialic acid can be a marker for cancer 
diagnosis.3.36 Gangliosides are a natural source of sialic acids. The function of sialic acids in 
gangliosides is presently not completely understood.3.37 Improved methods of analysis would aid 
in the elucidation of their biochemistry. 
The analysis of the sialic acid content of gangliosides is challenging. The common 
Warren3.38 and Svennerholm3.39 color tests (the most commonly used assays for sialic acid3.40) 
employ high temperatures, harsh reagents, and suffer from interference with other carbohydrates. 
In addition, many assays require prior liberation of the sialic acids which often results in 
decomposition.3.41 In the case of enzymatic hydrolysis, incomplete sialic acid liberation can be a 
GM1 
 38
problem. Compound 3.1 can be used for the post-column HPLC detection of N-acetylneuraminic 
acid, the most commonly occurring sialic acid and GM1 (Figure 2.10), a commercially available 
ganglioside. The retention times and detection limits for N-acetylneuraminic acid, GM1, and the 
other analytes described above are summarized in Table 3.1. 
 
Table 3.1. Retention times and limits of detection (LOD) for various carbohydrates 
 
carbohydrate retention time 
(min) 
LOD  
(μg) 
D-fructose 10.1 2.3 
D-glucose 12.0 7.1 
maltohexaose 6.0 30.1 
maltotriose 7.3 35.8 
N-acetylneuraminic acid 7.2 45.4 
GM1 5.5 26.8 
 
3.5. Conclusion 
We have synthesized new boronic acid probe 3.1 and demonstrated its use as a detection 
agent in an automated post-column HPLC system. The selectivity of 3.1 for fructose promotes 
fructose monitoring in the presence of a large excess of glucose. The affinity of 3.1 for 
oligosaccharides and sugar-containing biomolecules such as GM1 allows for colorimetric 
monitoring upon chromatographic elution.  We are continuing to study the synthesis and 
properties of chromophoric and fluorophoric chemosensors and supramolecular materials as 
HPLC post-column reagents. 
3.6. Experimental Section 
3.6.1. Synthesis of Compound 3.1 
Rhodamine 110 (0.1 g, 0.27 mmol) and 2-formylphenylboronic acid (0.082 g, 0.54 mmol) 
are mixed in absolute EtOH (20 mL) and PhCH3 (3.1 mL).  A Dean-Stark trap is fitted and the 
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reaction mixture is heated at reflux overnight (18-24 hrs).  After cooling, the solvent is removed 
in vacuo to afford a yellow oil. Anhydrous MeOH (25 mL) is added and NaBH4 (0.041 g, 1.08 
mmol, 4 equiv) is added over 5 min. The reaction is stirred at rt. for 2 hr, and poured into ice-
water (10 mL). A small amount of saturated NaHCO3 (5 mg) is added. The aqueous solution is 
extracted with DCM (3 × 50 mL). The aqueous layer is collected, dried, and filtered. The solvent 
is removed in vacuo to afford (0.13g, 81%) of product. To obtain an analytical standard for 
sensing work, further purification is performed by reversed-phase HPLC using a Dynamax 60Å 
C18 (21.4 mm ID × 25 cm L) column with a flow rate of 5 mL/min. and a gradient of 70/30 
MeOH/H2O to 100% MeOH in 30 min.  Data for 3.1: 1H NMR (300 MHz, DMSO-d6): 4.53 (s, 
4H), 6.74-6.86 (m, 4H), 7.11-7.23 (m, 8H), 7.58-7.63 (m, 2H), 8.05 (d, J = 7.2 Hz, 2H), 8.54 (s, 
2H).  13C NMR (500 MHz, DMSO-d6): 22.07, 28.66, 28.95, 46.45, 97.17, 105.85, 114.91, 
118.83, 122.48, 124.05, 124.33, 125.24, 126.38, 128.13, 128.83, 129.73, 150.87, 152.33, 154.98, 
168.87. FAB-MS m/z (glycerol matrix) calcd for C34H28B2N2O7 598.22 M+, found 710.1[M + 2 
C2H6O2 – 4 H2O]+. 
3.6.2. Experimental Conditions 
HPLC experiments are performed on a CM4000 multiple solvent delivery system 
(LDC/Milton Roy) and a SpectroMonitor 3100 UV-Vis detector (LDC/Milton Roy) using a 
700CH carbohydrate column (6.5 × 300 mm, Alltech Associates Inc.). The column is maintained 
at constant temperature using a CH-30 column heater (Eppendorf). The post-column detection 
system consists of a He cylinder connected to a RDR-1 Reagent Delivery/Reaction Module 
(Timberline). The RDR-1 unit contains a pressurized reagent reservoir, a mixing tee, and a 
thermostated reaction block with a Teflon reaction coil (0.02 in ID × 1 mL) with a nominal 
volume of 0.2 mL. The HPLC column is connected to the RDR-1. The RDR-1 is attached to a 
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SpectroMonitor 3100 UV-Vis detector (LDC/Milton Roy). The column temperature is set to 85 
ºC and the temperature of the reaction block to 50 ºC. Absorbance is monitored at 560 nm except 
for sialic acid and GM1 which are monitored at 520 nm. The reagent consists of a solution of 3.1 
in 0.05 M buffer (pH=10.5, carbonates). The final concentration of 3.1 is 4.0 x 10-6 M. The 
reagent is introduced at a flow rate of 0.5 mL/min and the reactor temperature kept at 50 ºC. The 
mobile phase is 100 % deionized H2O. All UV-Visible spectra were recorded on a Spectramax 
Plus 384 spectrophotometer (Molecular Devices). 
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CHAPTER 4 
ORIGIN OF COLOR FORMATION FROM RESORCINARENE SOLUTIONS*,4,1 
4.1. Introduction 
Resorcinarenes have been employed in a wide range of applications including molecular 
recognition, materials science, and supramolecular chemistry. Recently, we reported that strong 
color formation can occur upon heating of solutions containing resorcinarene macrocycles4.2 and 
its use for the sensing of saccharides.4.2 These colorimetric properties were initially observed by 
von Baeyer in 18724.3 when he synthesized resorcinarene macrocycles during his studies on the 
condensation reaction of resorcinol and benzaldehyde in the presence of acid.4.3 He observed that 
the resultant solution underwent a color change from red to violet upon the addition of base. 
However, further investigation of this observation has not been pursued. In this section, the 
origin of color formation in resorcinarene macrocycles is discussed in detail. 
4.2. Results 
Davis and Lewis of the Strongin group reported that the acid promoted condensation 
reaction of commercially available 4-formylphenyl boronic acid and resorcinol produced 
compounds 4.1 and 4.2a in one step in a combined yield of 91%.4.4 White crystalline solids were 
obtained via the separation of the two stereoisomers by fractional crystallization.  
Colorless DMSO solutions (5.2 mM) containing crystalline compounds 4.1 and 4.2a upon 
standing for several hours at room temperature or for 1 min at 90 °C developed a color change 
from colorless to pinkish-purple. 
Davis and Lewis found that the presence of oxygen or light was directly related to the color 
promotion of DMSO solutions of resorcinarenes. 
 
* Reproduced in part with permission from Journal of the American Chemical Society, 2002, 
Volume 124, pages 5000-5009; Copyright 2002 American Chemical Society. 
 44
HO OH
OH
OH
R
OH
OH HO OH HO OHHO HO
HO OH
B(OH)2 B(OH)2
B(OH)2 B(OH)2
HO
HO
4.2a  R=
4.2b  R=CH3
4.1
HO OH
X X
4.3a X=Br, R=
4.3b X=H, R=CH3
4.3c X=C12H25, R=
OH OH
RR R
B(OH)2
R
B(OH)2
B(OH)2 
 
Figure 4.1. Resorcinarene macrocycles 4.1 and 4.2 and related condensation products 4.3 
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Figure 4.2. Common xanthene dyes 
 
Initial studies showed that heated solution containing 4.1 in DMSO under oxygen-degassed 
condition or in the dark produced relatively decreased intensity in color. 4.2 For example, heating 
a solution containing 4.1 (5.2 mM) in oxygen-degassed DMSO, produced decreased absorbance 
at 535 nm up to 61%. Additionally, heating an acylated derivative of 4.1 on phenolic hydroxyls 
to reflux did not exhibit any color formation.4.5 
 45
350 400 450 500 550 600 650 700
0.0
0.1
0.2
0.3
0.4
0.5
0.6
A
bs
or
ba
nc
e 
(A
U
)
Wavelength (nm)
 4.6a
 4.2a
 4.3a
 
Figure 4.3. Overlayed UV-Vis spectra of the solutions of 4.2a and 4.3a each in DMSO (0.9 mL) 
were gently refluxed over 2 min and cooled to room temperature followed by the addition of 
H2O (0.1 mL) to each solution.  The final concentrations of 4.2a and 4.3a are 1.03 × 10-3 M and 
1.96 × 10-3 M respectively.  A solution of 4.6b (5.0 × 10-6 M) was prepared in 9:1 DMSO:H2O at 
room temperature. 
 
Thus, the phenolic hydroxyls also played an important role in the formation of 
chromophores.  Heating solutions of resorcinol or phenylboronic acid individually or an 
equimolar mixture of those with or without the added sugars under the same reaction conditions 
produced only pale color changes by visible detection.4.2 Thus, they reasoned that effective 
chromophore formation also required the methine-bridge of resorcinol and aldehyde 
condensation. 
Interestingly, methine-bridged condensation products of resorcinol/aldehyde were known as 
reaction intermediates in the syntheses of well-known xanthene dyes which include fluorescein, 
rhodamine, 4.6a, 4.6b, and ethyl eosin (4.6c).  
Indeed, the UV-Vis spectrum of 4.6b exhibits an absorbance maximum at 530 nm and, less 
intensely, at 500 nm. Those xanthene spectral patterns are similar to those seen in DMSO 
solutions containing 4.1, 4.2a, 4.2b, and 4.3a.4.5 
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Figure 4.4. A computer-simulated structure of condensation product of macrocyclic compound 
4.1 (Sybyl® ver. 6.6). 
 
A computer-simulated structure study of 4.1 by Sybyl® ver. 6.6 by Jorge Escobedo showed 
that the formation of planar xanthene substructure within resorcinarene macrocycles increases in 
strain energy by 34.2 kcal/mol. Thus, the ring opening of resorcinarene macrocycles to acyclic 
oligomers could be a prerequisite to promote xanthene dyes in solution. It was also well-
documented that 4.2b and its macrocyclic stereoisomers could interconvert through their acyclic 
oligomer intermediates in acidic media.4.6 Since the ring opening of resorcinarene macrocycles 
had only been reported to occur in the presence of strong acid, the formation of acyclic 
oligomers in a mixture of DMSO and H2O (9:1) without the addition of any acid required the 
further investigation. 
Solutions containing 4.1 (5.2 mM) in DMSO-d6 were heated for 3 min at 90 °C (the same 
procedure as in the initial study of colorimetric sugar detection) and monitored by 1H and 13C 
NMR spectrophotometer. They did not show any noticeable change in peak integral and 
chemical shifts compared to those of pure and colorless samples.4.2 In fact, only a trace amount 
of xanthene dye needs to be produced since xanthene dyes are highly absorbing materials. Figure 
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4.3 shows that approximately 0.5% conversion of 4.1 affords detectable colorimetric properties 
in solution. 
We observed that more vigorous conditions were required to afford significant amounts of 
conversion products. Fresh 4.2b (100 mg, 18.4 mM) in DMSO was heated at 120 °C for 8h and 
monitored by reversed phase high performance liquid chromatography (HPLC) which revealed a 
74% conversion of 4.2b to numerous products in a basis of relative peak integrals.  
 
 
 
Figure 4.5. X-ray crystal structure of (CH3)3S+CH3SO3- 
 
D. Swern and co-workers found that DMSO by the presence of peroxides and oxygen could 
promote acidic products which lead to the certain oxidations.4.7 Free radical scavengers have 
been used to inhibit acid formation from DMSO decomposition.4.7c We observed that the same 
thermolytic condition as described above, but with added free radical scavengers (either 
phenothiazene or BHT, 10 mol %) promoted less than 28% conversion to products monitored by 
HPLC. 
Our recent publication described the strong evidence of the acid formation from DMSO 
decomposition by determining the first X-ray crystal structure of (CH3)3S+CH3SO3- from a 
thermolysis reaction of 4.2b in DMSO.4.8 The precedent literatures reported that the radical- and 
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acid-promoted decomposition of DMSO could afford (CH3)3S+CH3SO3- along with other 
decomposition products including CH3SOH, CH3SO2H, CH3SO3H.4.9 
 
 
Figure 4.6. X-ray crystal structure of a “diamond” stereoisomer (4.7). 
 
We also found strong evidence to prove the ring opening of resorcinarene macrocycles. R. 
Johnson isolated a rarely found “diamond” stereoisomer4.10 from the thermolysis reaction of 4.2b 
in DMSO followed by column chromatography (2.3% yield). Slow evaporation of 4.7 in a 
mixture of CH2Cl2 and MeOH (9:1) afforded X-ray quality crystals. Transformation of 4.2b to a 
“diamond” structure of resorcinarene is only possible to form via the ring-opening/re-
condensation of 4.2b. Weinelt and Schneider previously assigned the structure of 4.7 as in the 
octabutyrate form via NMR study during their studies of macrocyclic stereoisomer 
interconversions in acidic media.4.6 
The thermolysis of 4.2b followed by preparative HPLC separation allows us to observe a 
key acyclic product, 4.3b. The comparison of the 1H NMR spectrum (Figure 4.7) of the isolated 
compound with a sample which we independently synthesized shows each of the corresponding 
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resonances of 4.3b (CH3OD δ 1.46, d, J = 7.3 Hz, 4.53, q, J = 7.3 Hz, 6.18-6.22, m, 6.89, d, J = 
8.0 Hz). In addition, the MALDI mass spectrometer data of the HPLC isolate shows a peak at 
245.59 amu (246.26 amu calcd). 
 
 
 
Figure 4.7.  (Top) An expanded 1H NMR spectrum of semipurified thermolysis products with 
the resonances of 4.3b. (Bottom) An expanded 1H NMR spectrum of pure 4.3b. 
 
HO OH
O
4.8  
 
Figure 4.8. 2,4-dihydroxyacetophenone 
 
The formation of 4.3b and 4.7 under our thermolysis conditions supports our hypothesis of 
acid-promoted ring opening and acyclic interconversions of resorcinarenes.4.6 In a DMSO 
solution containing 4.3b (0.880g, 3.576 mmol) was saturated with air and heated at 100 °C for 
28h. The thermolytic products of 4.3b were determined by relative peak integrals of 1H NMR 
spectrum. The major product was resorcinol (90%) along with several minor products including 
2,4-dihydroxyacetophenone (4.8) and xanthene dye (4.6a). The ratio of peak integrals of 
resorcinol (triplet, 6.94 ppm in CH3OH-d4) to 2,4-dihydroxyacetophenone (doublet, 7.76 ppm) is 
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153:1. Just small traces of 4.6a (doublet, 7.65 ppm) were observed. The production of 4.8 
provides a link with prior work by Weinelt and Schneider.4.6  
My discovery of 4.6a afforded the first experimental proof that Baeyer’s reaction in 1872 
afforded colored xanthene dyes and that this was the material responsible for the color in our 
resorcinarene solutions which allowed us to develop sugar sensors.  Because acid and peroxides 
can promote oxidation of xanthenes,4.11 we should obtain a better conversion of xanthene dye 
(4.6a) from 4.3a by the presence of these reagents. 
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OHHO
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4.3b 4.6a
OHO OH
 
 
 
Figure 4.9. An expanded 1H NMR spectra of the oxidation product of 4.3b showing the 
formation of 4.6a. 
 
Indeed, I found that the most significant conversion (4% yield) to 4.6a was afforded by 
heating a solution of 4.3b (50 mg, 0.203 mmol), H2SO4 (0.15 mL), and K2S2O8 (1.0 mg) in 
MeOH (1.5 mL) to reflux for 2 h.   
4.3. Conclusion 
We have elucidated the mechanisms of the origin of color formation from resorcinarene 
macrocycles originally observed in von Baeyer’s condensation reaction. Our mechanistic studies 
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suggest that the color formation of resorcinarenes occurs via acid-promoted ring 
opening/condensation followed by oxidation to xanthenes. The in situ acid formation is 
attributed to the radical decomposition of DMSO. 
4.4. Experimental Section 
Matrix Assisted Laser Desorption Ionization mass spectra were recorded on a Bruker 
Proflex III MALDI mass spectrometer using either anthracene or dithranol matrices. UV-Visible 
spectra were acquired on a Spectramax Plus 384 spectrophotometer (Molecular Devices). 
Analytic and preparative HPLC separations were recorded on a Milton Roy CM4000 multiple 
solvent delivery system equipped with a LDC Analytical Spectromonitor 5000 photodiode array 
detector. A Dynamax 60Å C18 (21.4 mm ID × 25 cm L) column was used. Experimental 
conditions were followed; a gradient elution from 50% H2O and MeOH to 100% MeOH in 20 
min and a flow rate of 5 mL/min otherwise stated above. Compound 4.1,4.4 4.2a,4.4 4.2b,4.12 
4.3a,4.5 4.3b4.6 and 4.6a4. 13  were as prepared according to the previous literature. All other 
compounds were purchased from Sigma-Aldrich and used without further purification. 1H NMR 
spectra were recorded on a Bruker DPX-250, DPX-400, or AMX-500 spectrometer with a 
reference either by DMSO (2.45 ppm) or (CH3)4Si (0.00 ppm). 
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CHAPTER 5 
ONGOING RESEARCH IN THE DETECTION OF BIOLOGICALLY IMPORTANT 
MOLECULES 
5.1. Detection of α-Dicarbonyl Compounds 
The selective detection of α-dicarbonyl compounds is of great importance. Advanced 
glycation end products (AGEs) have been linked to numerous diseases including Alzheimer’s 
disease, diabetes, rheumatoid arthritis and aging process.5.1,5.2 It is known that α-dicarbonyl 
compounds are directly involved in AGEs. Glyoxal and methylglyoxal, α-dicarbonyl 
compounds, are major contributors in the formation of AGEs.5.2 In addition, methylglyoxal is, 
in particular, the most reactive precursor for AGE formations.5.2 The elevated levels of 
reactive α-dicarbonyl compounds including methylglyoxal and glyoxal have been found in 
diabetic patients.5.3 It is also known that the rate of AGE formations is increased by 
hyperglycemia in diabetes.5.4 Glyoxal along with arabinose has also been recognized as 
intermediates in glucose-induced protein crosslinking and autoxidative glycosylation.5.5 In 
addition, methyl glyoxal has been reported as a mutagenic compound towards Salmonella 
typhimurium TA 100 and Escherichia coli.5.6 
5.2. Selective Detection of the DNA Lesion Compound 
Recently the C1’-oxidized abasic DNA lesion (2-deoxyribonolactone) has attracted great 
attention owing to its mutagenicity.5.7  
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Scheme 5.1. Formation of butenolide. 
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The generation of 2-deoxyribonolactone in DNA has only been studied in model system 
by DNA-damaging agents including γ-radiolysis.5.7 
However, in vivo formation of 2-deoxyribonolactone and its biological function have 
been rarely studied.5. 8    Only recently, a selective detection method towards 2-
deoxyribonolactone has been introduced according to using a biotin-avidin strategy. The 
biotinylated cysteine reacts with the butenolide formed upon treatment of 2-
deoxyribonolactone with N,N’-dimethylethylenediamine (DMEDA). The resultant biotin 
adducts (Figure 5.1) binds to an avidin-horseradish peroxidase conjugate which can oxidize 
1,2-diaminobenzene in the solution to afford optical signal at 490 nm. 
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Figure 5.1. Biotin-butenolide adduct. 
 
5.3. Results 
Therefore, we reasoned that cysteine-conjugated rhodamine dye (5.2) would warrant a 
simple and selective detection method towards 2-deoxyribonolactone. Compound 5.2 is 
synthesized by a simple carbodiimide method. The activated N-Boc-S-tritylcysteine is 
acylated with commercially available rhodamine 110. Both N-Boc and S-trityl protecting 
groups are then removed by a mixture of trifluoroacetic acid and triethylsilane to attain 
compound 5.2. 
Initial studies show that solutions of 5.2 promote a significant increase in fluorescence 
emission upon addition of glyoxal (α-dicarbonyl compound) while malondialdehyde (β-
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dicarbonyl compound) or other structurally similar compounds acrolein and crotonaldehyde 
show only minimal changes in fluorescence intensity. (Figure 5.2)  
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Scheme 5.2. Synthesis of compound 5.2. 
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Figure 5.2. Fluorescence emission spectrum of 5.2 (2.3 x 10-5 M) with various analytes (5 x 
10-5 M) in 0.1 M pH 9.5 carbonate buffer. 
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We have also evaluated compound 5.2 as a potential indicator for the selective detection 
of 2-deoxyribonolactone. Upon addition of 5(2H)-furanone, a compound structurally similar 
to butenolide, the solution of 5.2 exhibits an exceptional selectivity over other analytes 
including DNA and RNA. 
We continue to study with compound 5.2 for the optimization of sensing conditions as 
well as for elucidation of the mechanism for the selective reaction of compound 5.2 on α-
dicarbonyl compounds. 
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Figure 5.3. Relative fluorescence emission intensity of 5.2 (1.5 x 10-8 M) with various 
analytes (2 x 10-3 M) in 0.1 M pH 9.5 carbonate buffer. 
 
5.4. Experimental Section 
Synthesis of compound 5.2; N-t-Boc-S-trityl-cysteine (695.4 mg, 1.5 mmol) and N-(3-
dimethylaminopropyl)-N’-ethyl-carbodiimide·HCl (287.55 mg, 1.5 mmol) are combined in 1 
mL of dry DMF and stirred for 30 min at 0 °C under N2. To the solution, are added 
rhodamine 110 (550.2 mg, 1.5 mmol) and N-ethylmorpholine (190.5 μL, 1.5 mmol). After 
stirring this solution for 30 min at 0 °C, the solution is stirred at room temperature for 
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overnight. The resultant mixture is poured into 90 mL of H2O and extracted with EtOAc (60 
mL × 3). The organic layer combined is filtered, dried with Na2SO4 and filtered again. The 
solvent is evaporated in vacuo to afford a crude product. For further purification, column 
chromatography is performed with EtOAc and hexanes (1:1) to attain 277.1 mg of 5.1 
(23.8 %). To the solution of 5.1 (61 mg, 78.7 μmol) in 0.8 mL of DCM, are added 
triethylsilane (39 μL, 244 μmol) and trifluoroacetic acid (0.8 mL, 10.4 mmol). The mixture is 
stirred for 1 hr under N2 at room temperature. After evaporating the solvent in vacuo, the 
resultant mixture is washed with hexanes (5 mL × 2) and the solvent is evaporated in vacuo to 
afford a crude product of 5.2. For further purification, C18 reverse phase HPLC is performed 
(100 % of H2O to 100 % of acetonitrile for 30 min, 1 % TFA) to attain the compound 5.2. 
Analytical data for 5.2; 1H NMR (250 MHz, CD3OD) δ (ppm): 3.08 (dd, J = 14.8 and 6.8 Hz, 
1H), 3.20 (dd, J = 14.8 and 5.0 Hz, 1H), 4.25 (dd, J = 6.8 and 5.0 Hz, 1H), 6.93 (s, 1H), 6.95 
(d, J = 9.8 Hz, 1H), 7.19 (d, J = 9.8 Hz, 1H), 7.23 (d, J = 8.8 Hz, 1H), 7.41 (d, J = 6.9 Hz, 
1H), 7.48 (d, J = 8.8 Hz, 1H), 7.83 (m, 2H), 8.33 (d, J = 8.7 Hz, 1H), 8.37 (s, 1H). MALDI-
MS m/z calculated for C23H19N3O4S 433.11 for M+, found 434.13 [M+H]+. 
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APPENDIX A: CHARACTERIZATION OF COMPOUND 1.1 
 
 
Figure A.1. 1H NMR spectra of 1.1 
 
 
 
Figure A.2. 13C NMR spectra of 1.1 
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Figure A.3. MALDI TOF MS spectra of 1.1 
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APPENDIX B: 1H NMR SPECTRA OF 1.2 
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APPENDIX C: 1H NMR SPECTRA OF 1.3 
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APPENDIX D: CHARACTERIZATION OF COMPOUND 1.5 
 
Figure D.1. 1H NMR spectra of 1.5 
 
 
Figure D.2. MALDI TOF MS spectra of 1.5 
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APPENDIX E: UV-VIS SPECTRUM OF COMPOUND 2.8 WITH VARIOUS AMINO 
ACIDS 
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Figure E.1. UV-Vis spectrum of the solution containing 2.8 (1.0 × 10-5 M, pH 7.3 15 mM 
phosphate buffer, 3:7 H2O:MeOH) was monitored with added alanine (1.0 × 10-4 M). The 
same condition was applied for all other experiments in appendix B. 
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Figure E.2. UV-Vis spectra of 2.8 with glutamine 
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Figure E.3. UV-Vis spectra of 2.8 with lysine 
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Figure E.4. UV-Vis spectra of 2.8 with glycine 
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Figure E.6. UV-Vis spectra of 2.8 with methionine 
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Figure E.7. UV-Vis spectra of 2.8 with arginine 
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Figure E.7. UV-Vis spectra of 2.8 with threonine 
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Figure E.8. UV-Vis spectra of 2.8 with serine 
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APPENDIX F: UV-VIS SPECTRA OF FLUORESCEIN WITH ADDED Hcy 
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The added Hcy (1.0 × 10-4 M) to the solution of fluorescein (1.0 × 10-5 M, 50 mM 
phosphate at pH 7.3) do not afford any significant increase in UV-Vis spectra. 
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APPENDIX G: UV-VIS SPECTRA OF COMPOUND 2.8 WITH ADDED PPh3 AND 
Hcy 
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UV-Vis spectrum of the solution containing 2.8 (1.0 × 10-5 M, pH 7.3 15 mM phosphate 
buffer, 3:7 H2O:MeOH) with added PPh3 (5.0 × 10-4 M) and Hcy (1.0 × 10-5 M) showed no 
absorbance increase upon the addition of 30 equivalent of Cys to Hcy. 
 
 
 70
APPENDIX H: CHROMATOGRAM OF Cys USING 2.6 AS A DERIVATIZATION 
REAGENT 
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APPENDIX I: CHARACTERIZATION OF COMPOUND 3.1 
 
 
 
Figure I.1. 1H NMR spectra of 3.1 
 
 
 
Figure I.2. FAB MS spectra of 3.1 
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APPENDIX J: INTERCONVERSIONS OF MACROCYCLIC STEREOISOMERS 
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Interconversions of macrocyclic stereoisomers. 4.6 (D: pentamers, five resorcinol units) 
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APPENDIX K: THE IN SITU ACID FORMATIONS VIA THE DECOMPOSITION 
OF DMSO IN RADICAL AND ACID PATHWAYS 
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The in situ acid formations via the decomposition of DMSO in (a) radical and (b) acid 
pathways.4.9 
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APPENDIX L: CHARACTERIZATION OF COMPOUND 5.1 
 
Figure L.1. 1H NMR spectra of 5.1 
 
 
Figure L.2. ESI MS spectra of 5.1 
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APPENDIX M: CHARACTERIZATION OF COMPOUND 5.2 
 
Figure M.1. 1H NMR spectra of 5.2 
 
 
Figure M.2. MALDI TOF MS spectra of 5.2 
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APPENDIX N: LETTERS OF PERMISSION 
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